Data / New clinical trials / Colitis, Ulcerative

Colitis, Ulcerative trials: 328 new since Nov 2024

Name: New Colitis, Ulcerative clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Colitis, Ulcerative clinical trials: 328 rows for $16.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 16 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/colitis-ulcerative, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

328 clinical studies in Colitis, Ulcerative were first posted on ClinicalTrials.gov from November 12, 2024 to November 6, 2026; 89 have an industry sponsor and 241 are recruiting or about to. The newest, NCT07923383, was posted on November 6, 2026: An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450... (Sanofi).

The request: Every new Colitis, Ulcerative clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

328New trials
89Industry sponsored
241Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 328, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07923383	An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates	Sanofi	Phase 1	Not yet recruiting	Ulcerative Colitis, Crohn's Disease	25		clinicaltrials.gov
November 5, 2026	NCT07920367	Non-Invasive Biomarker Monitoring in UC on Biologics	University Hospitals Coventry and Warwickshire NHS Trust	Observational	Not yet recruiting	Ulcerative Colitis	99	United Kingdom	clinicaltrials.gov
November 4, 2026	NCT07916727	Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study	Austin Health	Not applicable	Recruiting	Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), Pregnancy	50	Australia	clinicaltrials.gov
November 4, 2026	NCT07916493	Effects of Different Physical Activity Strategies on Disease Activity of IBD Patients	Szeged University	Not applicable	Not yet recruiting	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)	150		clinicaltrials.gov
November 3, 2026	NCT07913347	Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)	Metagen Therapeutics, Inc.	Phase 1/2	Recruiting	Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate	54	Japan, United States	clinicaltrials.gov
October 28, 2026	NCT07900945	Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants	Keymed Biosciences Co.Ltd	Phase 1	Not yet recruiting	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)	48	China	clinicaltrials.gov
October 22, 2026	NCT07888023	Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease	Assiut University	Observational	Not yet recruiting	Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative (UC), Malnutrition	210		clinicaltrials.gov
October 16, 2026	NCT07878026	Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)	Jinling Hospital, China	Early phase 1	Not yet recruiting	Pouchitis, UC - Ulcerative Colitis	12	China	clinicaltrials.gov
October 16, 2026	NCT07877649	Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease	First Affiliated Hospital, Sun Yat-Sen University	Observational	Not yet recruiting	Inflammatory Bowel Diseases (IBD), Crohn Disease, Colitis, Ulcerative	2,000		clinicaltrials.gov
October 16, 2026	NCT07877636	Objective Disease Control and Treatment Strategies in Ulcerative Colitis	First Affiliated Hospital, Sun Yat-Sen University	Observational	Not yet recruiting	Ulcerative Colitis (Disorder)	1,000		clinicaltrials.gov
October 13, 2026	NCT07871669	Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).	Wuhan Kangfude Urolithiasis Research Institute Co., Ltd.	Phase 2	Not yet recruiting	Enteric Hyperoxaluria	30		clinicaltrials.gov
October 9, 2026	NCT07869225	A Phase I, Randomized, Double-Blind, Placebo-Controlled Study of EQ504 in Single and Multiple Ascending Doses in Healthy Volunteers	Equillium	Phase 1	Not yet recruiting	Ulcerative Colitis	70	Australia	clinicaltrials.gov
October 5, 2026	NCT07857447	The Effects of a Modified Mediterranean Diet on Ulcerative Colitis Patients	University Hospital Sestre Milosrdnice	Not applicable	Not yet recruiting	Ulcerative Colitis (UC)	62	Croatia	clinicaltrials.gov
October 2, 2026	NCT07855055	Early Changes in Inflammatory Indices and Healing in IBD	Assiut University	Observational	Not yet recruiting	Inflammatory Bowel Disease, Ulcerative Colitis, Crohn Disease	138		clinicaltrials.gov
October 1, 2026	NCT07851207	A Study to Assess Guselkumab in Participants With Moderate-to-Severe Inflammatory Bowel Disease in Real Life Italian Setting	Janssen-Cilag Ltd.	Observational	Not yet recruiting	Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases	200		clinicaltrials.gov
September 30, 2026	NCT07848737	A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis	Janssen-Cilag, S.A.	Observational	Not yet recruiting	Colitis, Ulcerative, Crohn Disease	200	Spain	clinicaltrials.gov
September 29, 2026	NCT07845487	A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis	Palisade Bio	Phase 2	Recruiting	Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis	204	Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania...	clinicaltrials.gov
September 22, 2026	NCT07834515	Phase 1b Clinical Study in Patients With Active Ulcerative Colitis	Thetis Pharmaceuticals LLC	Phase 1	Not yet recruiting	Ulcerative Colitis (UC)	24		clinicaltrials.gov
September 18, 2026	NCT07828886	Immune Aging and Advanced Therapy Outcomes in Older Adults With IBD	First Affiliated Hospital, Sun Yat-Sen University	Observational	Not yet recruiting	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Frailty, Immunosenescence	300		clinicaltrials.gov
September 17, 2026	NCT07824726	Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory...	PhoenixLAB srls	Not applicable	Not yet recruiting	Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease), Crohn Disease (CD)	30	Italy	clinicaltrials.gov
September 15, 2026	NCT07820046	Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis	Tanta University	Phase 2/3	Recruiting	Ulcerative Colitis (UC)	44	Egypt	clinicaltrials.gov
September 15, 2026	NCT07819799	Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis	Attovia Therapeutics Inc	Phase 1	Not yet recruiting	Ulcerative Colitis (UC)	96		clinicaltrials.gov
September 14, 2026	NCT07818473	Conventional vs Biologic Therapy in Pediatric IBD	Assiut University	Observational	Not yet recruiting	Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis	100		clinicaltrials.gov
September 11, 2026	NCT07814456	Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors	First Affiliated Hospital of Kunming Medical University	Phase 2	Recruiting	Ulcerative Colitis (UC), Inflammatory Bowel Disease	200	China	clinicaltrials.gov
September 10, 2026	NCT07814274	Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development	University of British Columbia	Observational	Not yet recruiting	Inflammatory Bowel Disease (IBD)	95	Canada	clinicaltrials.gov
September 4, 2026	NCT07804511	Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission	University Hospital, Grenoble	Not applicable	Not yet recruiting	Inflammatory Bowel Diseases (IBD), Fatigue, Crohn Disease (CD), Ulcerative Colitis (UC)	120	France	clinicaltrials.gov
September 2, 2026	NCT07799506	Accurately Profiling the Changes and Functions of Key Microflora in the Whole Intestinal Microenvironment Based on the Visual Sampling...	Changhai Hospital	Observational	Not yet recruiting	Crohn's Disease (CD), Ulcerative Colitis (UC)	250		clinicaltrials.gov
September 2, 2026	NCT07799428	Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease	Anabio R&D	Not applicable	Recruiting	Crohn Disease and Ulcerative Colitis	150	Vietnam	clinicaltrials.gov
September 1, 2026	NCT07797998	Association of Diet and IBD	Assiut University	Observational	Not yet recruiting	IBD, Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)	100	Egypt	clinicaltrials.gov
September 1, 2026	NCT07796568	Virtual Group Therapy for IBD Patients With Anxiety and Depression	University of Chicago	Not applicable	Not yet recruiting	Crohn's Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD), Anxiety, Depression	16	United States	clinicaltrials.gov
August 28, 2026	NCT07791862	Familial Inflammatory Bowel Disease Early Risk	Seattle Children's Hospital	Observational	Recruiting	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn Disease (CD), Ulcerative Colitis (UC)	7,000	United States	clinicaltrials.gov
August 26, 2026	NCT07788131	Inflammatory Biomarkers and Disease Activity in Inflammatory Bowel Disease	Assiut University	Observational	Not yet recruiting	Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis (UC)	120		clinicaltrials.gov
August 26, 2026	NCT07786389	Seaweed Extract (Fucoidan) for Gut Inflammation in Ulcerative Colitis	Allama Iqbal Medical College	Phase 1/2	Enrolling by invitation	Ulcerative Colitis (UC)	90	Pakistan	clinicaltrials.gov
August 25, 2026	NCT07784114	Incremental Value of Traditional Chinese Medicine Features in Two-Stage Pre-Endoscopic Prediction	Beijing University of Chinese Medicine	Observational	Completed	Ulcerative Colitis (Disorder), Crohn Disease (CD), Inflammatory Bowel Diseases, Colorectal Neoplasms	1,500		clinicaltrials.gov
August 24, 2026	NCT07782242	Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UC	Sir Run Run Shaw Hospital	Phase 4	Not yet recruiting	Etrasimod, Mesalazine, Ulcerative Colitis (UC), Head-to-head	320		clinicaltrials.gov
August 24, 2026	NCT07781215	E-nose in Evaluating Colitis Activity	Tampere University Hospital	Observational	Not yet recruiting	IBD (Inflammatory Bowel Disease)	120		clinicaltrials.gov
August 20, 2026	NCT07775352	Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease	Mahidol University	Not applicable	Recruiting	Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative	137	Thailand	clinicaltrials.gov
August 19, 2026	NCT07773948	ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery	University Hospital, Linkoeping	Phase 4	Not yet recruiting	Ulcerative Colitis (UC), Pouchitis	110	Sweden	clinicaltrials.gov
August 17, 2026	NCT07768254	A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative...	Helixon Biotechnology (Suzhou) Co., Ltd	Phase 1	Not yet recruiting	Colitis, Ulcerative	32	China	clinicaltrials.gov
August 17, 2026	NCT07767370	ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea	The Second Hospital of Nanjing Medical University	Early phase 1	Recruiting	Diarrhea Chronic, UC - Ulcerative Colitis	36	China	clinicaltrials.gov
August 14, 2026	NCT07766733	The Safety and Efficacy of Good Feeling Power® for IBD Patients	Good Feeling Products GmbH	Not applicable	Completed	Ulcerative Colitis (UC), Crohn Disease (CD)	36	Spain	clinicaltrials.gov
August 11, 2026	NCT07758335	The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited...	National Hepatology & Tropical Medicine Research Institute	Phase 4	Recruiting	Ulcerative Colitis (UC)	132	Egypt	clinicaltrials.gov
August 10, 2026	NCT07755241	A Study of AC-101 Tablets in Patients With Ulcerative Colitis	Accro Bioscience (Suzhou) Limited	Phase 2	Recruiting	Ulcerative Colitis (UC)	153	China	clinicaltrials.gov
August 7, 2026	NCT07752446	Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission	Pontificia Universidad Catolica de Chile	Not applicable	Recruiting	Ulcerative Colitis (Disorder), Inflammatory Bowel Disease (IBD)	45	Chile	clinicaltrials.gov
August 7, 2026	NCT07751081	Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase...	University of Padova	Not applicable	Not yet recruiting	Inflammatory Bowel Disease, Ulcerative Colitis Type, Functional Disorder of Gastrointestinal Tract	50	Italy	clinicaltrials.gov
August 6, 2026	NCT07749768	A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and...	Ono Pharmaceutical Co., Ltd.	Phase 1	Recruiting	Ulcerative Colitis (UC)	90	United States	clinicaltrials.gov
August 5, 2026	NCT07747480	A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis	GlaxoSmithKline	Phase 1	Recruiting	Colitis, Ulcerative	16	United Kingdom	clinicaltrials.gov
August 5, 2026	NCT07747467	A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative...	GlaxoSmithKline	Phase 1	Recruiting	Colitis, Ulcerative	8	United Kingdom	clinicaltrials.gov
August 5, 2026	NCT07747155	A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active...	Pyrotech Therapeutics, Inc.	Phase 2	Not yet recruiting	Ulcerative Colitis (UC)	40	China	clinicaltrials.gov
August 5, 2026	NCT07746765	A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting	Janssen Sciences Ireland UC	Observational	Not yet recruiting	Crohn Disease, Colitis, Ulcerative	35		clinicaltrials.gov
August 4, 2026	NCT07744646	Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis	The First Affiliated Hospital of Anhui Medical University	Phase 1	Not yet recruiting	Ulcerative Colitis (UC)	10	China	clinicaltrials.gov
August 3, 2026	NCT07742410	The Fecal Immunoassay Occult Blood Test Combined With Calprotectin Sequential Linkage Imaging Endoscopy Screening Strategy for Monitoring...	Qilu Hospital of Shandong University	Observational	Not yet recruiting	Ulcerative Colitis (UC)	250		clinicaltrials.gov
July 31, 2026	NCT07740499	TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease	IRCCS San Raffaele	Observational	Not yet recruiting	Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)	80	Italy	clinicaltrials.gov
July 24, 2026	NCT07726888	Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis	Second Affiliated Hospital of Wenzhou Medical University	Observational	Recruiting	Ulcerative Colitis (Disorder), Guselkumab	97	China	clinicaltrials.gov
July 24, 2026	NCT07724990	A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis	Catholic University of the Sacred Heart	Not applicable	Recruiting	Ulcerative Colitis, Crohn Disease	20	Italy	clinicaltrials.gov
July 23, 2026	NCT07721987	Development and External Validation of a Machine Learning Model for Pre-Endoscopic Prediction of Montreal Disease Extent (E1/E2/E3) in...	Beijing University of Chinese Medicine	Observational	Active not recruiting	Ulcerative Colitis (Disorder)	1,500		clinicaltrials.gov
July 23, 2026	NCT07721441	Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative...	Tang-Du Hospital	Observational	Enrolling by invitation	Ulcerative Colitis (UC)	200	China	clinicaltrials.gov
July 22, 2026	NCT07719426	Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a...	Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives	Observational	Recruiting	Crohn Disease (CD), Colitis Ulcerative	800	France	clinicaltrials.gov
July 22, 2026	NCT07718529	Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative...	Assistance Publique Hopitaux De Marseille	Phase 4	Not yet recruiting	Ulcerative Colitis in Remission	224	France	clinicaltrials.gov
July 17, 2026	NCT07710287	Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD	IRCCS Policlinico S. Donato	Observational	Recruiting	Ulcerative Colitis (UC), Crohn Disease	100	Italy	clinicaltrials.gov
July 15, 2026	NCT07705126	A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC	Tang-Du Hospital	Observational	Not yet recruiting	Ulcerative Colitis (UC)	500	China	clinicaltrials.gov
July 14, 2026	NCT07700446	Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose	Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives	Phase 4	Not yet recruiting	Ulcerative Colitis (UC)	100		clinicaltrials.gov
July 13, 2026	NCT07697456	Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis	AbbVie	Phase 2	Recruiting	Crohn's Disease, Ulcerative Colitis	2,000	Canada, Israel, Japan, Taiwan, United States	clinicaltrials.gov
July 10, 2026	NCT07695636	Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study	IRCCS San Raffaele	Observational	Completed	Ulcerative Colitis (UC)	282	Italy	clinicaltrials.gov
July 10, 2026	NCT07694609	Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable Diseases	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Active not recruiting	Inflammatory Bowel Diseases (IBD), Crohn Disease, Ulcerative Colitis (UC)	200	Italy	clinicaltrials.gov
July 9, 2026	NCT07694362	Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease	Vall d'Hebron Institute Research	Not applicable	Completed	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Ulcerative Colitis (UC), Crohn's Disease...	60	Spain	clinicaltrials.gov
July 9, 2026	NCT07692165	A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis	Innatus Therapeutics (Shanghai) Co., Ltd.	Phase 1/2	Recruiting	Ulcerative Colitis (UC)	24	China	clinicaltrials.gov
July 8, 2026	NCT07691138	Stopping PPI Therapy in Inactive IBD	University of Nottingham	Phase 4	Recruiting	Ulcerative Colitis (UC), Crohn's Disease	80	United Kingdom	clinicaltrials.gov
July 7, 2026	NCT07686757	INSIGHT-IBD Pragmatic Study	Specialty Networks Research.	Phase 4	Enrolling by invitation	Ulcerative Colitis (UC), Crohn Disease (CD)	400	United States	clinicaltrials.gov
July 7, 2026	NCT07686406	IBD Biomarker Discovery and Validation Platform	Sixth Affiliated Hospital, Sun Yat-sen University	Observational	Recruiting	Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD)	6,000	China	clinicaltrials.gov
July 7, 2026	NCT07686081	Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis	Vanda Pharmaceuticals	Phase 3	Recruiting	Ulcerative Colitis (UC)	150	United States	clinicaltrials.gov
July 2, 2026	NCT07682038	Retrospective Observational Multicenter Study on the Treatment Patterns, Extra-Intestinal Manifestations, Resource Utilisation, and...	LOGEX	Observational	Not yet recruiting	Crohn Disease, Inflammatory Bowel Disease (IBD), Colitis Ulcerative	3,500		clinicaltrials.gov
June 29, 2026	NCT07673497	Can Vitamin D Replacement Correct Chronic Disease Anemia?	Gazi University	Phase 4	Completed	Vitamin D, Iron Deficiency and Overload, Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)	43	Turkey (Türkiye)	clinicaltrials.gov
June 26, 2026	NCT07671313	Online Pain Education for Crohn's Disease and Ulcerative Colitis	Cedars-Sinai Medical Center	Not applicable	Not yet recruiting	Crohn's Disease, Ulcerative Colitis (UC), Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)	60	United States	clinicaltrials.gov
June 26, 2026	NCT07670975	Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)	Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria	Observational	Recruiting	Crohn Disease Colitis, Colitis, Ulcerative, Inflammatory Bowel Diseases	50	Italy	clinicaltrials.gov
June 24, 2026	NCT07665294	Combination CurQD and Vedolizumab in Ulcerative Colitis	Ryan C Ungaro	Phase 4	Not yet recruiting	Ulcerative Colitis	160	Israel, United States	clinicaltrials.gov
June 23, 2026	NCT07663201	Cardiovascular Risk in Patients With IBD	IRCCS Policlinico S. Donato	Observational	Not yet recruiting	Ulcerative Colitis (UC), Crohn's Diseases, Cardiovascular Risk	300		clinicaltrials.gov
June 23, 2026	NCT07662902	Ulcerative Colitis Permeability	University Hospital Dubrava	Observational	Enrolling by invitation	Ulcerative Colitis (UC), Steatotic Liver Disease, Intestinal Permeability	100	Croatia	clinicaltrials.gov
June 18, 2026	NCT07656233	Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life...	Universitas Indonesia	Not applicable	Completed	Ulcerative Colitis (UC), Crohn Disease (CD)	50	Indonesia	clinicaltrials.gov
June 17, 2026	NCT07654751	A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically	Janssen Research & Development, LLC	Phase 4	Recruiting	Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic	10	United States	clinicaltrials.gov
June 17, 2026	NCT07653750	Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis	University Hospital, Clermont-Ferrand	Not applicable	Terminated	Moderate to Severe Ulcerative Colitis	62	France	clinicaltrials.gov
June 17, 2026	NCT07652840	Treatment Adherence Among Patients With Inflammatory Bowel Disease Receiving Anti-TNF Therapy	Izmir Katip Celebi University	Not applicable	Completed	Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), Adherence, Patient, Structured Education	140	Turkey (Türkiye)	clinicaltrials.gov
June 17, 2026	NCT07652294	Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Spyre Therapeutics, Inc.	Phase 2	Enrolling by invitation	Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative	645	Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia...	clinicaltrials.gov
June 16, 2026	NCT07650942	Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis	Ganzhou Hemay Pharmaceutical Co., Ltd	Phase 3	Not yet recruiting	Ulcerative Colitis (UC)	360	China	clinicaltrials.gov
June 15, 2026	NCT07647640	Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study	Maastricht University Medical Center	Observational	Recruiting	Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD)	600	Netherlands	clinicaltrials.gov
June 12, 2026	NCT07646223	Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis	Tampere University Hospital	Phase 2	Not yet recruiting	Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC), Pediatric Inflammatory Bowel Diseases	140	Finland	clinicaltrials.gov
June 12, 2026	NCT07644117	Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease	Shmuel Kivity, MD	Observational	Recruiting	IBD (Inflammatory Bowel Disease), Crohn Disease (CD), Ulcerative Colitis (UC)	40	Israel	clinicaltrials.gov
June 11, 2026	NCT07640659	Using Breath Tests to Study Gut Sulfur Changes During Dietary Therapy	University of British Columbia	Not applicable	Not yet recruiting	Ulcerative Colitis (UC)	45	Canada	clinicaltrials.gov
June 9, 2026	NCT07637045	Urinary PGE-MUM as a Marker for Ulcerative Colitis Activity	Assiut University	Observational	Not yet recruiting	Ulcerative Colitis (UC)	114	Egypt	clinicaltrials.gov
June 9, 2026	NCT07636304	VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission	University of Gdansk	Early phase 1	Enrolling by invitation	Inflammatory Bowel Diseases (IBD), Remission of IBD, In Adults, Inflammatory Bowel Disease (Crohn's Disease; Ulcerative...	15	Poland	clinicaltrials.gov
June 8, 2026	NCT07632573	A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult	Benethera (Shaoxing) Biotechnology Co., Ltd.	Phase 1	Recruiting	Ulcerative Colitis (UC), Ulcerative Colitis (Disorder), Ulcerative Colitis Acute, IBD (Inflammatory Bowel Disease), CD...	68	China	clinicaltrials.gov
June 2, 2026	NCT07621783	Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context	Imelda GI Clinical Research Center	Observational	Recruiting	Crohn Disease (CD), Ulcerative Colitis (UC)	100	Belgium	clinicaltrials.gov
June 2, 2026	NCT07619638	AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis	ENBIOSIS BIOTECHNOLOGIES	Not applicable	Not yet recruiting	Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Colitis	162	Turkey (Türkiye)	clinicaltrials.gov
June 2, 2026	NCT07619547	Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Observational	Recruiting	Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis	100	United States	clinicaltrials.gov
May 28, 2026	NCT07610694	Eating Disorders in Patients With IBD	Federico II University	Observational	Completed	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn Disease (CD), Ulcerative Colitis (UC)...	355	Italy	clinicaltrials.gov
May 27, 2026	NCT07609810	Palmitoylethanolamide in Ulcerative Colitis	Ain Shams University	Not applicable	Recruiting	Ulcerative Colitis (UC)	60	Egypt	clinicaltrials.gov
May 27, 2026	NCT07608198	Validation of the Reliability and Validity of the New Endoscopic Scoring System for Ulcerative Colitis (CAT-DESIRE Score) and Verification...	Xijing Hospital of Digestive Diseases	Observational	Completed	Ulcerative Colitis (UC)	235	China	clinicaltrials.gov
May 26, 2026	NCT07606339	A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis	Janssen-Cilag Pharma GmbH	Observational	Recruiting	Crohn Disease, Colitis, Ulcerative	35	Austria	clinicaltrials.gov
May 18, 2026	NCT07593352	Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)	Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji	Observational	Recruiting	IBD and Renal Involement, Chronic Kidney Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)	6,000	Poland	clinicaltrials.gov
May 15, 2026	NCT07591012	Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease	University of Padova	Not applicable	Recruiting	Ulcerative Colitis (Disorder)	40	Italy	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Assiut University	8	October 22, 2026
Second Affiliated Hospital of Wenzhou Medical University	8	July 24, 2026
AbbVie	7	July 13, 2026
Sanofi	6	November 6, 2026
Sixth Affiliated Hospital, Sun Yat-sen University	5	July 7, 2026
Xijing Hospital of Digestive Diseases	5	May 27, 2026
Qilu Hospital of Shandong University	4	August 3, 2026
IRCCS San Raffaele	4	July 31, 2026
Eli Lilly and Company	4	March 19, 2026
First Affiliated Hospital, Sun Yat-Sen University	3	October 16, 2026
Tanta University	3	September 15, 2026
University of British Columbia	3	September 10, 2026
Pontificia Universidad Catolica de Chile	3	August 7, 2026
University of Padova	3	August 7, 2026
Tang-Du Hospital	3	July 23, 2026
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives	3	July 22, 2026
Assistance Publique Hopitaux De Marseille	3	July 22, 2026
IRCCS Policlinico S. Donato	3	July 17, 2026
Janssen Research & Development, LLC	3	June 17, 2026
University Hospital, Clermont-Ferrand	3	June 17, 2026

By phase

Phase	New trials	Latest
Observational	132	November 5, 2026
Not applicable	87	November 4, 2026
Phase 2	40	October 13, 2026
Phase 4	23	August 24, 2026
Phase 1	20	November 6, 2026
Phase 3	11	July 7, 2026
Phase 1/2	7	November 3, 2026
Early phase 1	5	October 16, 2026
Phase 2/3	3	September 15, 2026

By country

Country	New trials	Latest
China	69	October 28, 2026
United States	67	November 3, 2026
Italy	39	September 29, 2026
Canada	33	September 29, 2026
France	33	September 29, 2026
Poland	28	September 29, 2026
Germany	26	June 17, 2026
United Kingdom	21	November 5, 2026
Japan	21	November 3, 2026
Czechia	17	September 29, 2026
Australia	15	November 4, 2026
Spain	15	September 30, 2026
Hungary	15	September 29, 2026
Egypt	15	September 15, 2026
Israel	15	July 13, 2026
Turkey (Türkiye)	15	June 29, 2026
South Korea	15	June 17, 2026
Belgium	14	June 17, 2026
Netherlands	14	June 15, 2026
Austria	13	June 17, 2026
Taiwan	12	July 13, 2026
Greece	12	June 17, 2026
India	12	May 11, 2026
Brazil	11	June 17, 2026
Romania	10	September 29, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.